Literature DB >> 29411698

Lenalidomide in non-deletion 5q lower-risk myelodysplastic syndromes: a glass quarter full or three quarters empty?

Rory M Shallis1, Amer M Zeidan1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29411698     DOI: 10.1080/10428194.2018.1430797

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  1 in total

1.  Identification of Lenalidomide Sensitivity and Resistance Mechanisms in Non-Del(5q) Myelodysplastic Syndromes.

Authors:  Leylah M Drusbosky; Christopher R Cogle
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.